Zhengye Biotechnology Holding (ZYBT) Accounts Payables (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Accounts Payables data on file, last reported at $55974.1 in Q4 2025.

• Accounts Payables for Q4 2025 came in at $55974.1, down 92.84% year-over-year; the trailing twelve-month figure through Dec 2025 was $55974.1 (down 92.84% YoY), and the FY2025 annual result was $6.3 million, up 718.73% from the prior year.
• Accounts Payables retreated to $55974.1 in Q4 2025 per ZYBT's latest filing, from $58000.0 in the prior quarter.
• Over five years, Accounts Payables peaked at $781974.7 in Q4 2024 and troughed at $55974.1 in Q4 2025.
• A 3-year average of $253188.3 and a median of $87402.1 in 2023 frame the typical range for Accounts Payables.
• The sharpest annual moves came in 2024 and 2025: Accounts Payables jumped 569.47% in 2024, then sank 92.84% in 2025.
• A 3-year view of Accounts Payables shows it stood at $116804.3 in 2023, then jumped by 569.47% to $781974.7 in 2024, then slumped by 92.84% to $55974.1 in 2025.
• Business Quant data shows ZYBT's Accounts Payables at $55974.1 in Q4 2025, $58000.0 in Q2 2025, and $781974.7 in Q4 2024.